APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin E2 Receptor EP2 Subtype

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prostaglandin E2 Receptor EP2 Subtype Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchProstaglandin E2 Receptor EP2 Subtype Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin E2 Receptor EP2 Subtype Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Prostaglandin E2 Receptor EP2 Subtype Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin E2 Receptor EP2 Subtype Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin E2 Receptor EP2 Subtype Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Prostaglandin E2 Receptor EP2 Subtype market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prostaglandin E2 Receptor EP2 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin E2 Receptor EP2 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin E2 Receptor EP2 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prostaglandin E2 Receptor EP2 Subtype market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prostaglandin E2 Receptor EP2 Subtype market include Sanofi, Santen Pharmaceutical Co., Ltd., Amgen Inc., Ono Pharmaceutical Co., Ltd. and Ascendis Pharma A/S, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Prostaglandin E2 Receptor EP2 Subtype market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin E2 Receptor EP2 Subtype and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin E2 Receptor EP2 Subtype revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prostaglandin E2 Receptor EP2 Subtype market.

Prostaglandin E2 Receptor EP2 Subtype Segment by Company

Sanofi

Santen Pharmaceutical Co., Ltd.

Amgen Inc.

Ono Pharmaceutical Co., Ltd.

Ascendis Pharma A/S

Prostaglandin E2 Receptor EP2 Subtype Segment by Type

Treprostinil

TG-4155

SAR-366234

ONO-8055

Others

Prostaglandin E2 Receptor EP2 Subtype Segment by Application

Clinic

Hospital

Others

Prostaglandin E2 Receptor EP2 Subtype Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Prostaglandin E2 Receptor EP2 Subtype status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prostaglandin E2 Receptor EP2 Subtype key companies, revenue, market share, and recent developments.

3. To split the Prostaglandin E2 Receptor EP2 Subtype breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prostaglandin E2 Receptor EP2 Subtype market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostaglandin E2 Receptor EP2 Subtype significant trends, drivers, influence factors in global and regions.

6. To analyze Prostaglandin E2 Receptor EP2 Subtype competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin E2 Receptor EP2 Subtype market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin E2 Receptor EP2 Subtype and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin E2 Receptor EP2 Subtype.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostaglandin E2 Receptor EP2 Subtype industry.

Chapter 3: Detailed analysis of Prostaglandin E2 Receptor EP2 Subtype company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prostaglandin E2 Receptor EP2 Subtype in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prostaglandin E2 Receptor EP2 Subtype in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prostaglandin E2 Receptor EP2 Subtype Industry Trends Table 2. Prostaglandin E2 Receptor EP2 Subtype Industry Drivers Table 3. Prostaglandin E2 Receptor EP2 Subtype Industry Opportunities and Challenges Table 4. Prostaglandin E2 Receptor EP2 Subtype Industry Restraints Table 5. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Company (2021-2026) Table 7. Global Prostaglandin E2 Receptor EP2 Subtype Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prostaglandin E2 Receptor EP2 Subtype Key Company Manufacturing Base & Headquarters Table 9. Global Prostaglandin E2 Receptor EP2 Subtype Company, Product Type & Application Table 10. Global Prostaglandin E2 Receptor EP2 Subtype Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prostaglandin E2 Receptor EP2 Subtype by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Treprostinil Table 15. Significant Companies of TG-4155 Table 16. Significant Companies of SAR-366234 Table 17. Significant Companies of ONO-8055 Table 18. Significant Companies of Others Table 19. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type (2021-2026) Table 23. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Clinic Table 25. Significant Companies of Hospital Table 26. Significant Companies of Others Table 27. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application (2021-2026) Table 31. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application (2027-2032) Table 32. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Region (2021-2026) Table 35. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Region (2027-2032) Table 37. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Market Share by Country (2021-2026) Table 40. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Market Share by Country (2027-2032) Table 42. Sanofi Company Information Table 43. Sanofi Business Overview Table 44. Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sanofi Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 46. Sanofi Recent Development Table 47. Santen Pharmaceutical Co., Ltd. Company Information Table 48. Santen Pharmaceutical Co., Ltd. Business Overview Table 49. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 51. Santen Pharmaceutical Co., Ltd. Recent Development Table 52. Amgen Inc. Company Information Table 53. Amgen Inc. Business Overview Table 54. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 56. Amgen Inc. Recent Development Table 57. Ono Pharmaceutical Co., Ltd. Company Information Table 58. Ono Pharmaceutical Co., Ltd. Business Overview Table 59. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 61. Ono Pharmaceutical Co., Ltd. Recent Development Table 62. Ascendis Pharma A/S Company Information Table 63. Ascendis Pharma A/S Business Overview Table 64. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 66. Ascendis Pharma A/S Recent Development Table 67. Research Programs/Design for This Report Table 68. Authors List of This Report Table 69. Secondary Sources Table 70. Primary Sources List of Figures Figure 1. Prostaglandin E2 Receptor EP2 Subtype Product Image Figure 2. Global Prostaglandin E2 Receptor EP2 Subtype Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin E2 Receptor EP2 Subtype Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin E2 Receptor EP2 Subtype Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Treprostinil Image Figure 8. TG-4155 Image Figure 9. SAR-366234 Image Figure 10. ONO-8055 Image Figure 11. Others Image Figure 12. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type (2021-2032) Figure 15. Clinic Image Figure 16. Hospital Image Figure 17. Others Image Figure 18. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application (2021-2032) Figure 21. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032) & (US$ Million) Figure 24. North America Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032) & (US$ Million) Figure 30. South America Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Treprostinil
  • TG-4155
  • SAR-366234
  • ONO-8055
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Santen Pharmaceutical Co., Ltd.
  • Amgen Inc.
  • Ono Pharmaceutical Co., Ltd.
  • Ascendis Pharma A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostaglandin E2 Receptor EP2 Subtype Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prostaglandin E2 Receptor EP2 Subtype Market Dynamics
  1. 2.1 Prostaglandin E2 Receptor EP2 Subtype Industry Trends
  2. 2.2 Prostaglandin E2 Receptor EP2 Subtype Industry Drivers
  3. 2.3 Prostaglandin E2 Receptor EP2 Subtype Industry Opportunities and Challenges
  4. 2.4 Prostaglandin E2 Receptor EP2 Subtype Industry Restraints
3 Prostaglandin E2 Receptor EP2 Subtype Market by Company
  1. 3.1 Global Prostaglandin E2 Receptor EP2 Subtype Company Revenue Ranking in 2025
  2. 3.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2026)
  3. 3.3 Global Prostaglandin E2 Receptor EP2 Subtype Company Ranking (2024-2026)
  4. 3.4 Global Prostaglandin E2 Receptor EP2 Subtype Company Manufacturing Base and Headquarters
  5. 3.5 Global Prostaglandin E2 Receptor EP2 Subtype Company Product Type and Application
  6. 3.6 Global Prostaglandin E2 Receptor EP2 Subtype Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prostaglandin E2 Receptor EP2 Subtype Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prostaglandin E2 Receptor EP2 Subtype Market by Type
  1. 4.1 Prostaglandin E2 Receptor EP2 Subtype Type Introduction
  2. 4.1.1 Treprostinil
  3. 4.1.2 TG-4155
  4. 4.1.3 SAR-366234
  5. 4.1.4 ONO-8055
  6. 4.1.5 Others
  7. 4.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type
  8. 4.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Type (2021-2032)
  10. 4.2.3 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type (2021-2032)
5 Prostaglandin E2 Receptor EP2 Subtype Market by Application
  1. 5.1 Prostaglandin E2 Receptor EP2 Subtype Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application
  6. 5.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Application (2021-2032)
  8. 5.2.3 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application (2021-2032)
6 Prostaglandin E2 Receptor EP2 Subtype Regional Value Analysis
  1. 6.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032)
  7. 6.3.2 North America Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032)
  10. 6.4.2 Europe Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032)
  16. 6.6.2 South America Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Country, 2025 VS 2032
7 Prostaglandin E2 Receptor EP2 Subtype Country-level Value Analysis
  1. 7.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prostaglandin E2 Receptor EP2 Subtype Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Santen Pharmaceutical Co., Ltd.
  8. 8.2.1 Santen Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Santen Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  12. 8.2.5 Santen Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Amgen Inc.
  14. 8.3.1 Amgen Inc. Company Information
  15. 8.3.2 Amgen Inc. Business Overview
  16. 8.3.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  18. 8.3.5 Amgen Inc. Recent Developments
  19. 8.4 Ono Pharmaceutical Co., Ltd.
  20. 8.4.1 Ono Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Ono Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  24. 8.4.5 Ono Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Ascendis Pharma A/S
  26. 8.5.1 Ascendis Pharma A/S Company Information
  27. 8.5.2 Ascendis Pharma A/S Business Overview
  28. 8.5.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  30. 8.5.5 Ascendis Pharma A/S Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst